A clinical trial led by University of Auckland researchers found that high-intensity therapy for patients begun within two weeks of a stroke did not improve hand and arm recovery beyond standard care.
Storied semiconductor and software company Arm Holdings is starting to make its own chips after nearly 36 years of licensing its designs to companies like Nvidia and Apple. At an event Tuesday in San ...
Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X “I’ve always been fascinated with things that cannot be explained,” Spielberg revealed in a 2026 ...
Solar winds and coronal mass ejections may scatter narrow signals, making them harder for Earth-based telescopes to detect. The SETI Institute uses radio telescopes to search for signs of intelligent ...
Aliens have invaded the news again. Last month, two US presidents weighed in on the topic in rapid succession, managing to make a public that was already obsessed with extraterrestrials even more so.
A massive UK study of more than 165,000 dementia patients has uncovered troubling new evidence about risperidone, a commonly used drug for severe agitation. Researchers found the antipsychotic ...
Interested in how the nervous system shapes movement and balance? Join us to study real-time brain–muscle interactions in aging and stroke. Many people after stroke, and even healthy older adults, ...
The risk of recurrent ischemic stroke can be reduced by managing modifiable risk factors and instituting a regimen of mechanism-specific secondary stroke prevention. Strategies for secondary ...
Liberal podcast host Brian Tyler Cohen defended his questioning of former President Barack Obama on Monday after the former president's response to a question about aliens went viral and revealed that ...
Former President Barack Obama said he did not see evidence that aliens "have made contact with us," after sending social media abuzz by saying aliens were real on a podcast over the weekend. During a ...
Targeted therapy of the ipsilesional, or “good” arm, improved motor function, including control and speed, in chronic stroke survivors with severe paresis. In a small randomized clinical trial ...
The National Institutes of Health (NIH) halted a treatment arm of Bayer and Johnson & Johnson’s Xarelto (rivaroxaban) in a phase 3 stroke prevention trial after an independent committee flagged safety ...